Market Access/ News/ News CHMP backs J&J’s myeloma CAR-T therapy Carvykti Phil Taylor Abecma, BCMA Targeted Therapies, Bristol-Myers Squibb, CAR-T therapies, Carvykti, immuno-oncology, Johnson & Johnson, multiple myeloma, Oncology 0 Comment Johnson & Johnson is in course for approval of its multiple myeloma CAR-T therapy Carvykti in the EU Share X CHMP backs J&J’s myeloma CAR-T therapy Carvykti https://pharmaphorum.com/news/chmp-backs-jjs-myeloma-car-t-therapy-carvykti/